Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-20 7:09 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,807,315 13.8% | 23,683 (+0.63%) | View |
| 2024-02-14 4:58 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | CITADEL ADVISORS LLC | 3,276 0% | -1,558,705 (-99.79%) | View |
| 2024-02-14 4:21 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 1,680,517 6.1% | -296,351 (-14.99%) | View |
| 2024-02-14 3:08 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 1,211,696 4.38% | -745,436 (-38.09%) | View |
| 2024-02-09 4:28 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | TCG Crossover GP I LLC | 2,201,274 8% | 2,201,274 (New Position) | View |
| 2023-06-27 5:00 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | RA CAPITAL MANAGEMENT L.P. | 8,293,148 30% | 29,166 (+0.35%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 1,976,868 8% | 145,079 (+7.92%) | View |
| 2023-02-14 3:10 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 1,957,132 7.95% | 126,441 (+6.91%) | View |
| 2023-02-14 08:02 am Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | CITADEL ADVISORS LLC | 1,561,981 6.4% | -35,498 (-2.22%) | View |
| 2023-02-03 7:24 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,783,632 15.4% | 23,558 (+0.63%) | View |
| 2022-12-15 4:06 pm Sale | 13D | AEROVATE THERAPEUTICS INC AVTE | Atlas Venture Fund XII L.P. | 2,039,249 8.3% | -304,180 (-12.98%) | View |
| 2022-07-20 4:22 pm Sale | 13D | AEROVATE THERAPEUTICS INC AVTE | Atlas Venture Fund XII L.P. | 2,343,429 9.6% | -304,180 (-11.49%) | View |
| 2022-05-05 4:04 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Atlas Venture Fund XII L.P. | 2,647,609 10.8% | 2,647,609 (New Position) | View |
| 2022-02-14 4:14 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | BAKER BROS. ADVISORS LP | 1,831,789 7.5% | 1,831,789 (New Position) | View |
| 2022-02-14 3:10 pm Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 1,830,691 7.5% | -200,000 (-9.85%) | View |
| 2022-02-14 06:22 am Sale | 13G | AEROVATE THERAPEUTICS INC AVTE | CITADEL ADVISORS LLC | 1,597,479 6.5% | -27,695 (-1.70%) | View |
| 2021-11-05 4:38 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Atlas Venture Associates XII LLC | 3,103,879 12.7% | 3,103,879 (New Position) | View |
| 2021-07-13 1:49 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | Sofinnova Venture Partners X L.P. | 3,760,074 16.3% | 3,760,074 (New Position) | View |
| 2021-07-12 5:13 pm Purchase | 13D | AEROVATE THERAPEUTICS INC AVTE | RA CAPITAL MANAGEMENT L.P. | 8,263,982 33.9% | 8,263,982 (New Position) | View |
| 2021-07-12 4:19 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | Cormorant Asset Management LP | 2,030,691 8.32% | 2,030,691 (New Position) | View |